Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy

AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo on Monday released high-level results from the TROPION-Breast02 Phase 3 trial.

Benzinga

QURE: Why Analysts See Up to 63% Upside After 250% Single-Day Pop

Biotech stock uniQure just popped nearly 250% in one day, with an analyst calling its trial results "amazing". Wall Street sees significant upside to come.

MarketBeat

Samsung Galaxy Watches will 'soon' detect warning signs for heart failure

Apple made a splash with hypertension alerts; now Samsung will tackle its own serious health condition: Heart failure.

Android Central

From analysis to the latest developments in health,
read the most diverse news in one place.

I wore the Circular Ring 2 for three weeks and wanted to love it — but one big thing held it back

The Circular Ring 2 is a long-lasting, subscription-free smart ring with advanced, holistic tools like ECG readings, blood oxygen monitoring, and AFib detection but a buggy app limits its appeal for now.

Tom’s Guide

Anti-abortion groups furious as FDA approves generic abortion pill

Abortion rights supporters hail win for evidence-backed medicine as Evita Solutions’ generic version of mifepristone given approval

The Guardian - US

Trump administration approves generic version of abortion pill after RFK Jr had FDA review drug’s safety

The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’

The Independent UK

The Best Biotech ETFs to Buy

Biotech ETFs offer investors exposure to the most innovative and growth-oriented industry within the traditionally defensive healthcare sector.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

Conservatives rage after FDA approves generic abortion drug

The decision adds to conservative scrutiny of the agency and Commissioner Marty Makary.

Axios

Top 2 Health Care Stocks That May Keep You Up At Night This Month

As of Oct. 2, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga

Mountain Dew, Gatorade and Cheetos to undergo makeover amid health fears

PepsiCo is looking at purple sweet potatoes and carrots to color drinks like Mountain Dew and Cherry 7Up

The Independent UK

Popular frozen fruit recalled over potentially damaging health risk

The frozen fruit was sold in retailers across the U.S.

The Independent UK

Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On?

Shares of Tempus AI Inc (NASDAQ:TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here’s what investors need to know.

Benzinga

EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions

Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Wednesday the formalization of multiple commercial group purchasing organization (GPO) agreements for its new drug, Arbli (losartan potassium) Oral Suspension, 10 mg/mL.

Benzinga

Walmart sets a timeline for removing synthetic dyes and other additives from its food brands

Walmart says it plans to remove synthetic dyes and 30 other food additives from its store brands sold in the United States by January 2027

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Federal agencies blame Democrats for looming shutdown in apparent Hatch Act violation

Housing and VA departments attack ‘radical left’ despite law limiting political activities of government employees

Reason

Can Americans Trust RFK Jr.'s Health Advice? A Breakdown on Vaccines, Autism, Food Dyes, and More

As ever, be cautious about what you hear from the Department of Health and Human Services.

Bored Panda

Woman’s ‘Kybella’ Face Transformation Stuns People After Her Extreme Recovery Phase Goes Viral

Bored Panda contacted four dermatologists and plastic surgeons to find out more about Kybella, the FDA-approved treatment that targets the stubborn "double chin."

The Independent UK

Here are some effects of a government shutdown if Congress, Trump don't reach a deal

The U.S. government is nearing a partial shutdown, with a range of effects on public services and the broader economy

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

2 Penny Stocks That Wall Street Believes Can Soar Over 200%

Penny stocks are highly volatile, but some of them have the potential to deliver outsized returns.

We Got This Covered

RFK Jr. orders abortion pill ‘safety review’ based on junk science – just like his Tylenol autism claims

Guess which conservative think tank supplied the "evidence" for this one...

Benzinga

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or…

The Guardian - US

The abortion pill is safe. But why should Trump let facts get in the way?

RFK Jr is conducting a review of mifepristone, citing a deeply flawed study. The move could be devastating for women

The Guardian - UK

Pfizer sued in US over contraceptive that women say caused brain tumours

US class action lawsuit alleges company failed to warn about risks of using contraceptive injection Depo-Provera

MarketBeat

3 Healthcare Stocks Using AI to Drive Growth

AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation

Grocery Coupon Guide

9 Warning Signs a Restaurant Won’t Last Due to Bad Service

A great menu can’t save a place that treats guests poorly. Service sets the tone, protects margins, and builds repeat visits. When it’s bad, costs rise, reviews crash, and regulars vanish. You notice it fast: long waits, missing items, mixed-up bills. If you care about your time and money, spotting…

1 … 29 30 31 32

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.